The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing

Author： Chan Sze Ling   Suo Chen   Chia Kee Seng   Teo Yik Ying  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.11, 2012-08, pp. : 1247-1256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Survey on warfarin pharmacogenetic testing among anticoagulation providers

By Kadafour Maha   Haugh Roshanak   Posin Monica   Kayser Steven R   Shin Jaekyu  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1853-1860

Future Medicine

Access to resources Recommend Favorite

Validation of warfarin pharmacogenetic algorithms in clinical practice

By Marin-Leblanc Mélina   Perreault Sylvie   Bahroun Imen   Lapointe Mathieu   Mongrain Ian   Provost Sylvie   Turgeon Jacques   Talajic Mario   Brugada Ramon   Phillips Michael   Tardif Jean-Claude   Dubé Marie-Pierre  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 21-29

Future Medicine

Access to resources Recommend Favorite

Patients’ and physicians’ perspectives on pharmacogenetic testing

By Rogausch Anja   Prause Daniela   Schallenberg Anne   Brockmöller Jürgen   Himmel Wolfgang  

Pharmacogenomics, Vol. 7, Iss. 1, 2006-01 ,pp. : 49-59

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic Testing for Clopidogrel: State of the ART

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 203-215

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Polymorphisms in a Portuguese Gypsy Population

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 13, Iss. 1, 2015-12 ,pp. : 36-40

Bentham Science Publishers

Access to resources Recommend Favorite